Ventilator-associated pneumonia (VAP) is the second most common nosocomial infection among children treated in intensive care units. The risk factors for developing this condition are generated by the patient's bedside conditions, the equipment used and the specifi c treatment administered to the child. Prophylaxis of VAP should necessarily include all measures that have been proven to be effi cient in this respect such as rigorous hygiene control of hands and protective clothing of attending staff, changing breathing circuits of ventilators only if they malfunction or if they are visibly contaminated, preference of orotracheal intubation (instead of nasotracheal intubation) and use of endotracheal tubes with dorsal lumens to allow respiratory secretions to drain, and introduction of a uniform approach to patient care and staff training. Prophylaxis of the microbial colonization in children by antibiotics does not reduce the incidence of VAP-causing poly-resistant bacteria. Therapeutic management includes early initiation of broad spectrum empirical antibiotic therapy, the right choice of antibiotic requiring regular monitoring and good knowledge of the antibiotics sensitivity of the most common microbial isolates in the ward.
INTRODUCTION
The objective of the present review is to acquaint pediatricians and neonatologists with the tendencies and the established norms for VAP prevention and treatment. Despite the ever-increasing number of synthesized antimicrobial agents for VAP treatment, it is the prevention of this condition using a variety of hygienic, physiological and therapeutic approaches other than antibiotic therapy that is currently afforded the greatest signifi cance. There is no standard, universally accepted method by which VAP can be prevented according to the relevant literature. Morrow et al. consider it impossible to develop recommendations that would apply across all cases because of the yet unclear pathogenesis of the condition, different structure of the underlying pathology of children treated in pediatric intensive care units (PICU), different training and qualifi cation of the medical teams. 1 And yet the successes in this direction are all related to the introduction of uniform rules for the care of patients оn artifi cial lung ventilation (ALV). Moreover, the implementation of a system for registration and tracking of the changes in the antibiograms and antibiotic sensitivity of the resistant type facilitate the selection of an appropriate antibiotic or combination of antibiotics to treat it.
Foglia et al. fi nd that a comprehensive risk stratifi cation system incorporating preventable and nonpreventable risk factors might assist intensivists in the development of VAP prevention measures. Introduction of rules for early weaning of mechanical ventilation reduction of the risk for microaspiration is also considered necessary. 2 
PROPHYLAXIS OF VAP
VAP is still a challenge for today's intensive pediatrics and can afford a lot of leeway in reducing its incidence and mortality. There are commonly accepted recommendations on the hygiene of hands and protective clothing of personnel, the changing of breathing circuit of ventilators, the advantage of orotracheal intubation, the type of intubation tube, staff training and approach. There are many other issues such as head elevation, use of H 2 blockers, sucralfate or other antacid drugs and selective de- 
HEAD-OF-BED ELEVATION BY 30-45º
Head-of-bed elevation by 30-45º reduces the episodes and severity of gastro-esophageal refl ux, and hence micro-aspirations in children. Semirecumbent positioning has been demonstrated to contribute to VAP prevention in adult patients. There have been no in-depth studies on this issue in children. 2, 3 TRACHEOBRONCHIAL TREE TOILET Aspiration of secretions from the tracheobronchial tree is a routine procedure that ensures the patency of the lower respiratory tract (LRT) during the mechanical ventilation. Traditional open endotracheal suction requires disconnection from the ventilator which in most cases results in hypoxia and increased intratracheal pressure and increased mean arterial blood pressure in mechanically ventilated children. 2 Hypoxia can be avoided with the current methods of mechanical ventilation by delivering 100% oxygen in advance for several minutes. This creates oxygen pool in the blood and myoglobin. The closed aspiration systems for intubation require no disconnection of patients from the ventilator and keep it from retrograde microbial contamination. But these systems create greater risk than the open ones of bacterially contaminated secretions to pool in the ventilator and subsequently to be reinoculated in the patient's respiratory airways during the toilet.
There have yet been made no recommendations as to which tube aspiration system should be advisable to use in children. [2] [3] [4] Coffi n et al. report that subglottic secretion drainage is effective in reducing signifi cantly the early-onset VAP frequency. 5 This is possible if the intubation tubes are provided with cuffs and have dorsal lumen for aspiration. Hi-Lo Evac tube (Mallinckrodt) is just the type for that. Unfortunately, it is available only in sizes 6-9 Fr making it unsuitable for infants and young children.
ORAL HYGIENE Decontamination measures for oral cavity and dental care reduce the amount of bacteria there and subsequently the likelihood of colonization of LRT. This can be achieved by mechanical cleaning of the dental plaque and the use of solutions for oral hygiene. Medicinal decontamination is achieved by the use of different antiseptic solutions -e.g. twice daily 0.1% and 0.12% chlorhexidine. An alternative is the use of solutions of gentamicin, colistin and vancomycin applied 6 times daily. The optimal frequency of application of antiseptic solutions in children on ALV remains unknown. 2, 5, 6 
STRESS ULCER PROPHYLAXIS USING H 2 -BLOCKERS AND PROTON PUMP INHIBITORS
Gastric acidifi cation inhibits the development of pathogens. Increasing gastric pH by antacid drugs may lead to proliferation of the pathogenic fl ora which contaminates the LRT in aspiration of the gastric contents. A direct correlation has been found between antacid drug use and the increased risk for VAP in adults, but research on this is still scanty for children. Theoretically sucralfate can be used as an alternative stress ulcer prophylactic agent instead of H 2 -blockers and proton pump inhibitors. It does not affect gastric pH while reducing the risk of stress ulcer, gastritis and gastrointestinal bleeding. Yildizdas et al. report that there is no statistically signifi cant differences in the type of antacid therapy and the associated risks for the development of the VAP. 7 However, according to the recommendations by Coffi n et al. and Gadani et al. the use of H 2 -blockers and proton pump inhibitors in patients with low risk of gastrointestinal complications should be avoided. 5, 8 SELECTIVE DECONTAMINATION Selective decontamination means LRT exogenous colonization prophylaxis in children with tracheostoma and prophylaxis of the endogenous colonization in micro-aspiration of secretions from GIT. Foglia et al. fi nd that in mechanically ventilated children with tracheostomy topical application of a mixture of polymyxin E and tobramycine four times daily around the tracheostoma in the fi rst 2 postoperative weeks signifi cantly reduces LRT colonization. In this type of prophylaxis bacterial colonization of the tracheobronchial tree have been noticed only in 4% of the cases. 2 Comparatively, there are considerably more studies on adults and selective decontamination of gastrointestinal tract (GIT), for prophylaxis of the LRT colonization with poly-resistant Gram negative microorganisms. 9, 10 HAND HYGIENE OF STAFF One of the proven methods to combat nosocomial infections are measures to prevent cross contamination of patients in the ward. 11, 12 Pittet et al. report signifi cant bacterial contamination of the hands of medical personnel working with patients. 13 While understanding of the importance of hand hygiene of staff is not new, research on this issue in patients with VAP is recent. Foglia ventilation which convincingly demonstrate the role of hand hygiene. The fi rst reports a 3-fold decrease of respiratory infections incidence from 3.35 to 1.05 per 1000 patient-days (total stay of patients in the ward), with adequate rules for hand washing. Another prospective study reports a reduction of the VAP rates from 3.3/1,000 ventilator days to 1.0/1,000 ventilator days (number of days during which the patient was on mechanical ventilation). 2 
TRAINING OF STAFF
Despite the effectiveness of measures to control nosocomial infections, its benefi ts are minimal if it is not adequately and intelligently applied by medical personnel. A number of articles point out the benefi ts of various forms of training of the medical staff, attending to patients on mechanical ventilation. Training programs addressed to those working in intensive care for adults are prevailing in number. Brierley et al. believe that such qualifi cation improving programs for staff working with children (doctors and nurses) reduce the incidence of VAP. 14
TREATMENT
Treatment strategy in cases of suspected VAP is based on the belief that it is best to begin treatment with broad spectrum antibiotics and their subsequent replacement with a specifi c monotherapy agent, depending on the results of microbiological testing. Upon failure to isolate the cause from the material taken (blood culture, TA or NB-BAL) changes in therapy are at the discretion of the treating team and a steady clinical improvement of the patient. 2 There are quite a lot of reports for VAP treatment in childhood, but offi cial recommendations are published only for adult patients. The American Thoracic Society recommends early initiation of appropriate, broad spectrum therapy with a combination of antibiotics, exclusion from the treatment plan of preparations of antibiotic groups that have recently been administered to the patient and if possible a short course of treatment in children with uncomplicated VAP. 13 Rotstein et al. have made similar recommendations. 15 EMPIRICAL ANTIBIOTIC THERAPY As antibiotics of different classes have been widely used in outpatient practises an empirical antibiotic therapy (AT) must take into account the fact that VAP may be caused by multi-resistant microorganisms such as VRE (vancomycin-resistant enterococci), MRSA (methicillin-resistant S. aureus), ESBLs-producing Gram-negative bacteria, KPC (K. pneumoniae carbapenemases), imipenem resistant A. baumannii, imipenem resistant P. aeruginosa. 1, 16 At present, it is assumed as proven that children can be colonized by their own endogenous fl ora as a result of antibiotic pressure. Therefore, the EAT should be started earlier, it should involve a combination of broad spectrum antibiotics in adequate dosage and has to be continued long enough. 1, 2, 17 Early administration of antibiotics to which the agent is sensitive is directly related to the best effect of treatment and reduced mortality due to VAP. Preparations for EAT should be selected considering the underlying diseases, any recent hospitalizations and the administration of antibiotics, circulating resistant types in the ward, the need for invasive procedures, nutritional and immunological status of each individual patient. Preparations selected for EAT should be from a group different from the one used for selective decontamination, again because of the risk of resistance. A large number of antimicrobials for the treatment of VAP are currently in use, and these are broad spectrum III and IV generation cephalosporins, fl uorinated quinolones and carbapenems. 1, 2, 13, 15 The dosage and regimen for these are presented in Tables 1 and 2 .
Additional problems at the start of the EAT in children with VAP are the hyperhydration, kidney or liver failure, drug interactions and abrupt changes in the level of serum proteins. Hyperhydration is commonly seen in resuscitation of critically ill patients with hemodynamic instability and it results in a decrease of the concentration of water soluble antibiotics. Acute kidney or liver failure may delay the excretion of antibiotics and increase their toxicity. Sudden changes in serum proteins signifi cantly infl uence the levels of free antimicrobial preparations in the blood.
Although very rarely, children with VAP need to undergo carbo-hemoperfusion or dialysis. As a result, serum levels of drugs may fall signifi cantly below the required minimum inhibitory concentration. Therefore, in such cases only active monitoring can provide adequate serum level of the administered antibiotic and antimicrobial treatment. 1, 2 SPECIFIC (ETIOLOGIC) THERAPY Switching from combined antimicrobial therapy to monotherapy should be done immediately after obtaining the results from the microbiological tests and the antibiogram of the isolated causative. 16 is recommended for children with mucoviscidosis who have confi rmed colonization of P. aeruginosa. The aim is to avoid systemic side effects with repeated and prolonged antibiotic needs in these cases. We did not come across reports of large multicenter studies of their effect in children with VAP. Abu-Salah et al. report the protective effect of inhaled antibiotics with regard to VAP in patients with ventilator-associated bronchitis. 18 DURATION OF ANTIBIOTIC THERAPY So far there has been no consent as to how long antimicrobial therapy in patients with VAP should continue. The suggested 8-and 15-day courses have their advantages and disadvantages. In 8-day courses a lesser extent reinfection with polyresistant organisms has been observed. On the other hand recurrence of the infection is signifi cantly more often in these patients. Fear of shortcomings in negative 
IV generation cephalosporins
Cefepime 100 mg/kg 3 times daily i.v. 1, 20 In the absence of effect of antibiotic treatment 48-72 hours after its initiation it is necessary to search for a second microbial agent and reassessment of therapy. 1, 20 An exception to this rule is the evidence for some microbial agents, e.g. P. aeruginosa, which requires 14 days of treatment, P. jirovecii -21 days, and fungal infections -a two-week course. 1
Monobactams

CONCLUSIONS
Prophylaxis of VAP should necessarily include all measures that have been proven to be effi cient such as strict hygiene control of hands and protective clothing of attending staff, changing breathing circuits of ventilators only if they malfunction or if they are visibly contaminated, preference of orotracheal intubation (instead of nasotracheal intubation) and use of endotracheal tubes with dorsal lumens to allow respiratory secretions to drain, and introduction of a uniform approach to patient care and staff training In children treated in pediatric intensive units hand hygiene and staff training are signifi cantly correlated with decreased incidence of VAP. Staff training and measures for the strict application of the protocol for VAP are predominant for the prevention of the disease. There is still no defi nitive solution of the issue of head elevation in children, use of H 2 blockers, sucralfate or other antacid drugs for selective decontamination of the GIT. Therapeutic response includes early initiation of broad spectrum empirical antibiotic therapy. Its use for initial treatment of children on APV is suffi ciently justifi ed for. It must be consistent with the microorganisms isolated in the wars and their resistance type. 
